Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Training Therapists to Administer Contingency Management-Patient Phase - 3
This study is currently recruiting participants.
Verified by National Institute on Drug Abuse (NIDA), May 2008
Sponsors and Collaborators: National Institute on Drug Abuse (NIDA)
University of Connecticut Health Center
Information provided by: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier: NCT00249418
  Purpose

The purpose of this study is to train therapists to administer contingency management (CM). This project will train up to 42 community-based treatment providers about the rationale for and the specifics of administering CM. Initial training will occur in 2-day workshops, followed by weekly supervision in delivery of CM with test cases. We expect that the majority of therapists will achieve high levels of competence and adherence in administering CM treatment within 3-5 test cases, as measured by ratings of audiotapes. To examine the efficacy of CM, each therapist who achieves adherence and competence in delivering CM will administer standard treatment alone or standard treatment plus CM to substance-abusing outpatients. In the CM condition, patients will have the opportunity to win prizes ranging in value from $1 to $100 for submission of negative samples, and the treatment will be in effect for 12 weeks. In total, up to 200 patients will be randomly assigned to one of the two conditions. A research evaluator will conduct follow-up assessments, scheduled for 3, 6 and 9 months after treatment initiation.


Condition Intervention
Substance Abuse
Behavioral: Contingency management

U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title: Training Therapists to Administer Contingency Management-Patient Phase

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:
  • Drug use [ Time Frame: baseline and each follow-up ] [ Designated as safety issue: No ]
  • Retention [ Time Frame: each follow-up ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: January 2004
Estimated Study Completion Date: January 2009
Estimated Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)
Intervention Details:
    Behavioral: Contingency management
    Rewards valued $1-$100 for abstinence
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • age 18 years or older
  • meets DSM-IV criteria for cocaine abuse or dependence
  • English speaking (est. >90% of patients)

For those in drug-free programs, they must have initiated treatment within the past week. For methadone patients, they must be stabilized on a dose of methadone, defined as being on the same dose for at least 30 days and not currently requesting or being considered for a dose modification. Methadone patients must also have submitted at least 30% cocaine positive urine samples in the past 3 months.

Exclusion criteria:

  • acute uncontrolled psychiatric disorder (psychosis, suicidality) as determined by the SCID
  • dementia (<23 on the Mini Mental State Exam; Folstein & Folstein, 1975)
  • in recovery for pathological gambling
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00249418

Contacts
Contact: Ellen M Ciesielski, BA (860)679-4556 ciesielski@psychiatry.uchc.edu
Contact: Sheila Alessi, Ph.D. 860.679.1849 alessi@psychiatry.uchc.edu

Locations
United States, Connecticut
University of Connecticut Health Center Recruiting
Farmington, Connecticut, United States, 06030 2103
Contact: Nancy Petry, Ph.D.     860-679-2593     petry@psychiatry.uchc.edu    
Sponsors and Collaborators
University of Connecticut Health Center
Investigators
Principal Investigator: Nancy Petry, Ph.D. University of Connecticut Health Center
  More Information

Responsible Party: UConn Health Center ( Nancy Petry, Ph.D. )
Study ID Numbers: NIDA-16855-3, R01-16855-3
Study First Received: November 3, 2005
Last Updated: May 23, 2008
ClinicalTrials.gov Identifier: NCT00249418  
Health Authority: United States: Federal Government;   United States: Institutional Review Board

Keywords provided by National Institute on Drug Abuse (NIDA):
Contingency Management
Substance Abuse Treatment

Study placed in the following topic categories:
Mental Disorders
Substance-Related Disorders
Disorders of Environmental Origin

ClinicalTrials.gov processed this record on January 14, 2009